| |
| |
|
| Insider
Information: |
Aviezer David |
| Relationship: |
President & CEO, Direc... |
| City: |
Carmiel, Israel |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
418,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$110,603 |
|
|
| Total
Shares |
418,000 |
|
|
| Total
Value |
$110,603 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protalix Biotherapeutics |
PLX |
President & CEO, Direc... |
2009-04-16 |
0 |
2012-07-16 |
418,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2012-07-16 |
4 |
A |
$0.00 |
$0 |
I/I |
418,000 |
418,000 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2012-05-02 |
4 |
AS |
$7.13 |
$3,208,500 |
I/I |
(450,000) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2012-05-02 |
4 |
OE |
$0.12 |
$159,421 |
I/I |
450,000 |
450,000 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
CEO and President |
• • – |
2009-10-21 |
4 |
AS |
$9.36 |
$320,468 |
I/I |
(34,238) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
CEO and President |
• • – |
2009-10-21 |
4 |
OE |
$0.12 |
$29,699 |
I/I |
247,490 |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
CEO and President |
• • – |
2009-10-21 |
4 |
D |
$9.13 |
$29,700 |
I/I |
(3,253) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
CEO and President |
• • – |
2009-10-20 |
4 |
AS |
$9.45 |
$567,000 |
I/I |
(60,000) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
CEO and President |
• • – |
2009-10-19 |
4 |
AS |
$9.43 |
$1,414,500 |
I/I |
(150,000) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-12 |
4 |
D |
$3.48 |
$12,427 |
I/I |
(3,571) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-12 |
4 |
OE |
$0.12 |
$12,429 |
I/I |
103,571 |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-12 |
4 |
AS |
$3.41 |
$190,619 |
I/I |
(55,900) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-11 |
4 |
AS |
$3.41 |
$132,649 |
I/I |
(38,900) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-08 |
4 |
AS |
$3.40 |
$17,680 |
I/I |
(5,200) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-06 |
4 |
D |
$3.06 |
$9,367 |
I/I |
(3,061) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-06 |
4 |
OE |
$0.12 |
$9,367 |
I/I |
78,061 |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-06 |
4 |
AS |
$3.01 |
$60,200 |
I/I |
(20,000) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-05 |
4 |
AS |
$3.07 |
$66,312 |
I/I |
(21,600) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-05-04 |
4 |
AS |
$3.01 |
$100,534 |
I/I |
(33,400) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-04-20 |
4 |
D |
$2.55 |
$6,296 |
I/I |
(2,469) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-04-20 |
4 |
OE |
$0.12 |
$6,296 |
I/I |
52,469 |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-04-20 |
4 |
AS |
$2.51 |
$83,583 |
I/I |
(33,300) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-04-17 |
4 |
AS |
$2.56 |
$25,600 |
I/I |
(10,000) |
0 |
0 |
- |
|
| PLX |
Protalix Biotherapeutics |
President & CEO |
• • – |
2009-04-16 |
4 |
AS |
$2.50 |
$16,750 |
I/I |
(6,700) |
0 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
